Classified as Internal #
Gavi Alliance Board Workplan
Gavi Board Paper Type Jan-MarAprMay JuneJuly-Nov DecMar/Apr JuneNov/Dec Mar/Apr JuneNov/Dec Mar/Apr JuneNov/Dec
A.Strategy/Performance/Risk/MEL CEO's Report CEO's Report Discussion
DiscussionDiscussionDiscussionDiscussion DiscussionDiscussion DiscussionDiscussion 2021-2025 Strategy Strategy, Programmes and Partnerships: Progress, Risks and ChallengesDiscussion Discussion DiscussionDiscussionDiscussion Discussion Innovation TBDInformation Information
Private Sector Engagement TBDInformation InformationInformation
Civil Society and Community Engagement Approach TBDInformation
Partners' Engagement Framework Strategy, Programmes and Partnerships: Progress, Risks and ChallengesDiscussion
Discussion DiscussionDiscussionDiscussion DiscussionDiscussion DiscussionDiscussion Disease Surveillance and Diagnostics in Gavi 5.0 TBDDiscussion
Risk and Asurance Report Risk and Assurance ReportDecision DecisionDecisionDecisionDecision
2026-2030 Strategy TBDDecisionDecision
Discussion DiscussionDiscussionDiscussion Funding Policy Review TBDDecisionGuidanceDecision
Health Systems strategy TBDDecisionGuidanceDecision
Measurement Framework (Targets & Indicators) TBD DecisionGuidanceDecision Decision B.Vaccines & Sustainablity Typhoid TBD Information Pneumococcal AMC (Advance Market Commitment) TBDInformation Vaccine Investment Strategy Vaccine Investment StrategyDecisionDecision COVID-19 Vaccine Programme Update TBD InformationInformation Gavi's role in Pandemic Prevention, Preparedness and Response TBD TBDTBD Gavi's role in support to Regional and African manufacturing TBD TBDTBD C.
Policy Transparency and Accountability Policy Decision D.Country Programmes
Nigeria TBD
InformationInformationInformation
PNG TBD
Information Information
Strategic Partnership with India Strategic Partnerships with India
Information
Fiduciary risk assurance and financial management capacity building Fiduciary risk assurance and financial management capacity building
Information
Middle-Income Countries approach TBDInformation E.Finance/Audit & Investigations Annual Accounts Annual Financial Report DecisionDecisionDecisionDecisionDecision Financial Forecast Financial Update, including forecastDecisionDecisionDecisionDecisionDecision DecisionDecision DecisionDecision
Budget Financial Update, including forecastDecision DecisionDecisionDecisionDecision
Programme Funding Policy Consent AgendaDecision
Treasury Governance Policy Consent AgendaDecision
Treasury Risk Management Policy Consent AgendaDecision
Independent Auditor Selection and Evaluation Policy Consent AgendaDecision
Audit & Investigations Report Audit & Investigations ReportInformation InformationInformationInformationInformation F.Governance
Board Chair Appointment Consent AgendaDecision Decision
Board Vice Chair Appointment Consent AgendaDecision DecisionDecision
Committee Chair Appointments Consent AgendaDecisionDecision Decision Decision
Board and Committee Appointments Consent AgendaDecision DecisionDecision
IRC Appointments Consent AgendaDecision
CEO Appointment Consent AgendaDecision Decision
Secretary Appointment Consent AgendaDecision
Treasurer Appointment Consent AgendaDecision
Appointment of MD A&I Consent AgendaDecision
Amendments to Governance Documents (Statutes, By-Laws, Committee Charters) Consent AgendaDecision
IRC Terms of Reference Consent AgendaDecisionDecision
Audit & Investigations Terms of Reference Consent AgendaDecision
G. Reporting
Committee Chair Reports Committee Chair and IFFIm Board reports InformationInformationInformationInformationInformation InformationInformation InformationInformation IFFIm Chair Reports Committee Chair and IFFIm Board reports InformationInformationInformationInformationInformation InformationInformation InformationInformation Replenishment/Resource Mobilisaton Resource Mobilisation Update Discussion
DiscussionDiscussion
Discussion HR Report Closed Session InformationInformationInformationInformationInformation InformationInformation InformationInformation Annual Report on Implementation of the Gender Policy Annex to Strategy paper Information InformationInformationInformationInformation Board and Committee minutes Annex to Board pack/On BE as additional materials Information
InformationInformationInformationInformation InformationInformation InformationInformation H.Technical Briefing Sessions/Deep Dives
Malaria - Joint session with the Global Fund Discussion
Gavi 6.0 Deep Dive (TBD) Discussion
Gavi Forecasting/Resource Allocation Discussion
Complexity of Vaccine Manufacturing - presented by IFPMA/DCVMN Discussion
Country Performance - High Impact Countries Discussion
Country Performance - Fragile Countries Discussion
Mid-Term Evaluation Discussion
Discussion
2026 2027
Last updated - 22 November 2023
Next Board Meetings: 17-18 April 2024, Retreat
26-27 June 2024
4-5 December 2024
2024
2025
Board-2023-Mtg-04-Doc 01f

Board -202 3-Mtg -02 1
Minutes

Gavi Alliance Board Meeting
26 -27 June 2023
Global Health Campus, Geneva, Switzerland

1. Chair’s report

1.1 Noting that the meeting had been duly convened and finding a quorum of
members present, the meeting commenced at 14 .05 Geneva time on
26 June 202 3. Prof Jos é Manuel Barroso, Board Chair, chaired the meeting.

1.2 The Chair welcomed new Board members and Alternate members attending
for the first time, namely: Eduardo Retes of Honduras , Greg Widmyer of the Bill
& Melinda Gates Foundation and Me llissa Hisko of Canada .

1.3 The Chair welcomed a number of high -level observers from Brazil, Saudi
Arabia , South Africa and Spain . He also welcomed Kenneth Lay, International
Finance Facility for Immunisation (IFFIm ) Board Chair , and other directors of
the IFFIm Board , as well as representatives from Nestor Advisors , the external
firm which is undertaking the ongoing Board and Board Committee evaluation.

1.4 He provided a brief summary on a number of preparatory meetings that took
place on the eve of the Board meeting , including the meeting of the
Implementing Country Caucus and the All Chairs Group (ACG) .

1.5 The Chair highlighted the Gavi Mid -Term Review (MTR) event that had taken
place on 13 -15 June 2023 in Madrid at the invitation of the Government of
Spain , whom he thanked for their commitment to global health. He underlined
the importance of the MTR in reviewing the progress of Gavi ’s objectives and
commended the Alliance for reaching the milestone of 1 billion children
vaccinated since Gavi’s inception in 2000.

1.6 The Chair noted that during the closed session earlier that day he had informed
the Board of a critical development related to the CEO position. Dr Muhamm ad
Pate , who was expected to assume his role as the new Gavi CEO on
3 August 2023 had informed Prof Barroso on the eve of the Board meeting that
he will not be able to join Gavi as he has accepted a request to return and
contribute to his home country , Nigeria . The Chair explained that in view of this
the Board had agreed to appoint the Chief Operating Officer (COO) David
Marlow, as interim CEO (and therefore a non -voting Board member) until a new
CEO has been recruited . He noted that the Board had also received an update
from Mr Marlow on the Operational Excellence initiative during the closed
session .

1.7 Standing declarations of interest were tabled to the Board (Doc 01a in the Board
pack).